Endoscopic Devices - Southern Africa

  • Southern Africa
  • In Southern Africa, revenue in the Endoscopic Devices market market is projected to reach US$193.50m in 2024.
  • This revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 6.48%, which will result in a market volume of US$264.90m by 2029.
  • In a global context, the majority of revenue will be generated the United States, where it is expected to amount to US$10,390.00m in 2024.
  • In Southern Africa, the demand for endoscopic devices is increasing as healthcare facilities modernize and prioritize minimally invasive surgical techniques.

Key regions: Italy, United Kingdom, Netherlands, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Endoscopic Devices Market in Southern Africa is witnessing moderate growth, influenced by factors such as advancements in minimally invasive procedures, increasing healthcare expenditure, and a rising prevalence of gastrointestinal disorders among the population.

Customer preferences:
Consumers in Southern Africa are progressively favoring advanced healthcare solutions that emphasize minimally invasive techniques, reflecting a growing awareness of the benefits of faster recovery times and reduced hospital stays. This shift is driven by a younger, more health-conscious demographic that values efficiency and comfort in medical procedures. Additionally, increased access to information through digital platforms has empowered patients to seek specialized treatments for gastrointestinal disorders, contributing to a rising demand for innovative endoscopic devices.

Trends in the market:
In Southern Africa, the Endoscopic Devices Market is experiencing a notable shift towards the adoption of advanced minimally invasive techniques, driven by a growing awareness among consumers about the benefits of quicker recovery and shorter hospital stays. This trend is particularly influenced by a younger, health-conscious population that prioritizes comfort and efficiency in medical procedures. Furthermore, increased digital access to healthcare information is empowering patients to pursue specialized treatments for gastrointestinal disorders, thereby elevating the demand for innovative endoscopic solutions. This evolving landscape presents significant opportunities for industry stakeholders, including manufacturers and healthcare providers, who must adapt to meet the needs of a more informed and proactive patient base.

Local special circumstances:
In Southern Africa, the Endoscopic Devices Market is shaped by unique cultural and geographical factors, including a diverse population with varying health beliefs and access to healthcare services. Rural areas often face challenges in accessing specialized medical care, driving demand for portable and cost-effective endoscopic solutions. Additionally, local regulatory frameworks are evolving to encourage innovation and streamline approval processes, fostering a more competitive market landscape. These dynamics compel manufacturers to tailor their offerings to meet the specific needs of underserved communities while navigating a complex regulatory environment.

Underlying macroeconomic factors:
The Endoscopic Devices Market in Southern Africa is significantly influenced by macroeconomic factors such as healthcare funding, economic stability, and demographic trends. National economic health plays a crucial role, as countries experiencing growth can allocate more resources to healthcare, enabling hospitals to invest in advanced endoscopic technologies. Additionally, fiscal policies aimed at improving public health infrastructure promote greater access to medical devices. Global trends, such as rising healthcare costs and the increasing prevalence of gastrointestinal diseases, further drive demand for innovative and cost-effective endoscopic solutions tailored to the region's unique healthcare landscape.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)